11 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

REJUVENATE MODULAR STEM

FDA 510(k)
FDA Class 2 ·Orthopedic

Rejuvenate Modular Stems Stryker Ireland Carrigtwohill Industrial Estate Carrigtwohill County Cork, Ireland Rejuvenate Modular Necks Stryker Howmedica Osteonics Corp. Mahwah, NJ 07430. Stem Bodies Rejuvenate Modular consists of 6 modular stems bodies in sizes 7-12. The Modular Stem bodies are made of TMZF alloy, developed specifically for orthopaedic applications. Rejuvenate Modular Necks The Rejuvenate Modular Necks are made of Cobalt Chrome. The necks in this system consist of 4 lengths in 4 mm increments. They are 30 mm, 34 mm, 38 mm and 42 mm. They come in multiple neck angles and versions in each length. They are 127, 130 and 132. The versions are 0, 8, 16 degrees. In total there are 16 unique neck implants in the Rejuvenate Modular System.

FDA Enforcement
Class II ·Ongoing·Stryker Howmedica Osteonics Corp.·August 1, 2012

SHEEP ANTI-HUMAN IGD IMMUNOFIXATION GRADE KIT

FDA 510(k)
FDA Class 2 ·Immunology

VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV CONTROLS

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

SHELL POROUS WITH CLUSTER HOLES

FDA Adverse Event
Injury ·ZIMMER, INC.·Product code LPH·May 26, 2017

ADJUSTING DEVICE GAMMA3 DISTAL TARGETING RIGHT, STATIC

FDA Adverse Event
Malfunction ·STRYKER OSTEOSYNTHESIS-KIEL·Product code LXH·May 3, 2013

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

FDA Adverse Event
Injury ·BAXTER HEALTHCARE - SWINFORD·Product code KDJ·September 16, 2014

ARSTASIS ONE ACCESS SYSTEM

FDA Adverse Event
Injury ·ARSTASIS INC.·Product code DYB·May 3, 2011

MULTIPLE-SEE ATTACHED

FDA Adverse Event
Injury ·ST. JUDE MEDICAL·Product code OAD·March 24, 2009

Various products which were contract sterilized.

FDA Enforcement
Class II ·Ongoing·Anewmed Corporation·November 6, 2019

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024